Summary:
- This article examines the complex role of the tumor microenvironment in modulating immune responses, specifically focusing on how metabolic reprogramming in cancer cells influences T-cell exhaustion.
- It provides a comprehensive review of current immunotherapeutic strategies, highlighting the potential for targeting specific metabolic pathways to enhance the efficacy of checkpoint inhibitors in clinical oncology.